Talk:FDA v. Alliance for Hippocratic Medicine

Washington case
Masem: Sorry for the revert, I had saved the old version of the page. This article is about a specific court case (in Texas), which is completely unconnected to a different court case (Washington v. FDA), which is in Washington. If the Washington case should be mentioned anywhere, it is at mifepristone (or some Legality of mifepristone article or section), not here where it is an entirely different subject. It is not as though the Washington case overrules the Texas case, either, as they are just dueling (mostly-)nationwide injunctions. TE(æ)A,ea. (talk) 19:10, 9 April 2023 (UTC)


 * They are very much tied together and mentioned one without the other at this stage would be inappropriate. Both of them cannot be enforced at the same time and thus likely the Supreme Court will be involved to make a decision on this. Of course, this case is still some time from resolution, and in the larger picture, this injunction may not matter much, but right now, how this injunction works with the WA one is an unknonw. M asem  (t) 19:28, 9 April 2023 (UTC)
 * But they are not tied together—the only connection is that they touch upon the same subject. The Texas case is not about the Washington case, and the Washington case is not about the Texas case. Both are about mifepristone, and could be mentioned there, but there is no reason to mention outright the Washington case in this article. Maybe it should be mentioned as see-also, if it gets its own article. As it stands, this article is not about lawsuits regarding FDA approval of mifepristone (which would cover both), but about one lawsuit in particular about that issue. TE(æ)A,ea. (talk) 20:11, 9 April 2023 (UTC)
 * They are tied in the sense that for multiple states, both rulings would apply (had Kacsmaryk's ruling not been stayed), creating competing/contradictory demands on the FDA. FactOrOpinion (talk) 01:53, 23 April 2023 (UTC)

Use of the term "abortionists"
Use of the term "abortionists" in the "Ruling" section, outside of a quote, may violate Wikipedia's neutrality rules, because it is not the common or medical term for gynecologists or providers of abortion, but rather, the language of the plaintiffs in this case. The judge specifically adopts the language of the plaintiff, but I don't think we should unless quoting him. Nosecohn (talk) 12:31, 12 April 2023 (UTC)
 * In writing that section, I was paraphrasing the judge's opinion, which uses that term. In addition, in the absence of a good alternative, we should use the judge's language. TE(æ)A,ea. (talk) 15:34, 12 April 2023 (UTC)

Amicus briefs
There have been a substantial number of amicus briefs filed already (in the 5th Circuit), so I'm listing them here (with citations) because it's difficult to keep track of them on the RECAP item. (There are 136 filings as of the time I'm writing this comment.) I have already added the briefs of members of Congress in favor of and in opposition to the motion for stay; those of the several states, and perhaps others including that of the local governments, should also be added.
 * States of New York, Arizona, California, Colorado, Connecticut, Delaware, Hawaiʻi, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, North Carolina, Oregon, Pennsylvania, Rhode Island, Vermont, Washington, and Wisconsin, and the District of Columbia, in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 52-1, at 1 (5th Cir. Apr. 11, 2023).
 * Local Governments in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 125, at 21–22 (5th Cir. Apr. 12, 2023).


 * City of Austin, Texas
 * City of Baltimore, Maryland
 * City of Birmingham, Alabama
 * City of Boston, Massachusetts
 * Bucks County, Pennsylvania
 * City of Cincinnati, Ohio
 * City of Cleveland, Ohio
 * City of Columbus, Ohio
 * City and County of Denver, Colorado
 * Harris County, Texas Attorney Christian Menefee
 * County of Los Angeles, California
 * City of Madison, Wisconsin
 * Milwaukee County, Wisconsin
 * City of Minneapolis, Minnesota
 * Montgomery County, Maryland
 * City of Montgomery, Alabama
 * City of Newark, New Jersey
 * City of Oakland, California
 * Pima County Attorney’s Office, Arizona
 * City of Pittsburgh, Pennsylvania
 * City of Portland, Oregon
 * City of Sacramento, California
 * City of Santa Cruz, California
 * City of St. Paul, Minnesota
 * City of Tucson, Arizona
 * Travis County Judge Andy Brown
 * Travis County Attorney Delia Garza
 * Washtenaw County Prosecuting Attorney’s Office


 * Ethics and Public Policy Center in opposition to motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 120, at 1 (5th Cir. Apr. 12, 2023).
 * 240 Members of Congress in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 124, at A-1–A-13 (5th Cir. Apr. 12, 2023).
 * Physicians for Reproductive Health in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 63, at 1 (5th Cir. Apr. 11, 2023).
 * Human Coalition in opposition to motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 136, at 1 (5th Cir. Apr. 12, 2023).
 * Advancing American Freedom in opposition to motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 109, at 1 (5th Cir. Apr. 11, 2023).
 * Doctors for America and the Reproductive Health Coalition in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 127, at 1 (5th Cir. Apr. 12, 2023).
 * Pharmaceutical Companies, Executives, and Investors in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 118, at 1a–7a (5th Cir. Apr. 11, 2023).


 * Grace E. Colón, CEO, Board Member and Entrepreneur
 * Paul J. Hastings, CEO, Nkarta Inc.
 * Elizabeth Jeffords, Biotech CEO & Board Member
 * RA Capital Management, LP (Peter Kolchinsky, Managing Partner)
 * Ram Aiyar, Biotech Executive
 * Srinivas Akkaraju, MD, PhD, Managing General Partner, Samsara BioCapital
 * Martin Babler, President and CEO, Alumis Inc.
 * Elizabeth Bailey, Managing Director, RH Capital
 * Rita Balice-Gordon, CEO, Muna Therapeutics
 * Amanda Banks, MD, Advisor, Board Member, Cofounder and Former CEO, Blackfynn
 * C. Gordon Beck III, Founder and Managing Director, Princeton Biomedical Consulting LLC
 * Gregg Beloff, Managing Director, Danforth Advisors LLC
 * Jeremy Bender, CEO, Day One Biopharmaceuticals
 * Stephen Benoit, CEO, MDI Therapeutics
 * Heather Alisa Berger, Board Member and Investor
 * Kenneth A. Berlin, President and CEO, Ayala Pharmaceuticals
 * Biotechnology Innovation Organization
 * Paul Bolno, MD, President and CEO, Wave Life Sciences
 * Flavia Borellini, PhD, Retired biotech executive, Board Director
 * Daniel M. Bradbury, Executive Chairman, Equillium Inc.
 * Braidwell
 * Cadence OTC
 * Capstan Therapeutics
 * Abraham N. Ceesay, CEO
 * Cellevolve Bio Inc.
 * Sommer Chatwin, Partner, Braidwell
 * Jung E. Choi, Former Chief Business Officer, Global Blood Therapeutics
 * Bharatt Chowrira, PhD, JD, Biotech Executive
 * Scott Clarke, CEO, Ambagon Therapeutics
 * Kerry Clem, CCO
 * Ron Cohen, MD, President and CEO, Acorda Therapeutics, Inc.
 * Thomas A. Collet, PhD, President & CEO, Bilayer Therapeutics, Inc.
 * Gerald E. Commissiong, President & CEO, Todos Medical, Ltd. and Todos Medical USA, Inc.
 * Emily Conley, PhD, CEO of Federation Bio, Board Member of Nuvalent (NASDAQ: NUVL), TMRW Lift Sciences, and Medrio
 * Curae Pharma360 Inc.
 * Karim Dabbagh, President and CEO, Second Genome, Inc
 * Bassil Dahiyat, President and CEO, Xencor
 * David de Graaf, PhD, President and CEO, Reverb Therapeutics, Executive Chairman, Ability Biologics
 * Deep Track Capital
 * Steve Derby, CEO, General Ventures, Inc.
 * Clarissa Desjardins, CEO, Congruence Therapeutics (a Canadian company)
 * Douglas Doerfler, Founder and CEO, MaxCyte, Inc.
 * Joanne Dove Kotz, CEO, Jnana Therapeutics
 * Ken Drazan, CEO, ArsenalBio
 * Karen Drexler, Company Board Member
 * Doug Drysdale, CEO, Cybin
 * Eric Dube, PhD, President & CEO, Travere Therapeutics
 * Michael N. Dudley, PharmD, President and CEO, Qpex Biopharma
 * Barbara Duncan, Ovid Therapeutics, Board Director
 * Sandi Dunn, PhD, CEO, Phoenix Molecular Designs
 * Jens Eckstein, PhD, Managing Partner, Apollo Health Ventures
 * David M. Epstein, PhD, President and CEO, Black Diamond Therapeutics, Inc
 * Lavi Erisson, MD, CEO & President, Gensaic, Inc.
 * Jennifer Ernst, CEO, Tivic Health
 * EXXclaim Capital
 * EyePoint Pharmaceuticals
 * Eric A Floyd MS, MBA, PhD, Senior Vice President - Regulatory Affairs and Quality Assurance, Silence Therapeutics
 * Kristen Fortney, CEO and Board Member
 * Renee Gala, Biotech Executive & BOD Member
 * Scott Garland, Board Member, PACT Pharma
 * Deborah Geraghty, PhD, CEO, Anokion
 * Gilead Sciences, Inc.
 * Corey Goodman, PhD, Managing Partner, venBio Partners
 * Adam Gridley, President & CEO, Allay Therapeutics
 * David-Alexandre Gros, MD, CEO, Eledon Pharmaceuticals
 * Sheila Gujrathi, MD, Biotech Executive, Entrepreneur, and Board Chair
 * John Hallinan, Chief Development Officer, Danforth Advisors
 * Matthew Hammond, Principal, RA Capital Management, LP
 * Alex Harding, MD, Head of Business Development, CRISPR Therapeutics
 * Scott Harris, Chief Operating Officer, Cleave Therapeutics
 * Kate Haviland, President and Chief Executive Officer, Blueprint Medicines
 * Rekha Hemrajani, Biotech Executive and Board Member
 * Jenny Herbach, CEO, Adventris Pharmaceuticals
 * Patrick Heron, Managing Partner, Frazier Life Sciences
 * Stephen Hill, COO
 * Andrew Hirsch, President and CEO, C4 Therapeutics
 * Steven H. Holtzman, Chair, Camp4 Therapeutics
 * Reid Huber, PhD, Partner, Third Rock Ventures
 * Juvena Therapeutics
 * JeenJoo S. Kang, PhD, CEO, Appia Bio
 * Rosana Kapeller, MD, PhD, Biotech CEO and Board Member
 * Alex Karnal, CIO, Braidwell
 * Ciara Kennedy, CEO, Sorriso Pharmaceuticals
 * Nikole Kimes, CEO, Siolta Therapeutics
 * Kinexum
 * Nina Kjellson, Biotech Investor, Public and Private Biotech Board Member, Healthcare Non-Profit Leader
 * Arthur Klausner, Executive Chairman, Concarlo Therapeutics
 * Jeffrey D. Klausner, MD, MPH, Clinical Professor of Medicine, Population, and Public Health Sciences, Keck School of Medicine of the University of Southern California
 * Jak Knowles, MD, CEO, Affini-T Therapeutics
 * Walter H Koch, PhD
 * Peter Kolchinsky, Managing Partner, RA Capital Management, LP
 * Gautam Kollu, CEO & President, D2G Oncology
 * Adam Kolom, CEO, Related Sciences
 * Brian Kreiter, CEO, Braidwell
 * Mark Lappe, Chairman and CEO, Inhibrx
 * Russ Lebovitz, MD, PhD, CEO, Amprion Inc
 * Jonathan Leff, Partner, Deerfield Management
 * Dr. Jeremy M. Levin, Chairman and CEO, Ovid Therapeutics
 * Jonathan Lewis, MD, PhD, Chairman, Dugri, Inc.
 * Stanley Lewis, MD, MPH, Founder and CEO, A28 Therapeutics
 * Charlene Liao, PhD, President and CEO, Immune-Onc Therapeutics, Inc.
 * Ivana Liebisch, Biotech CEO and Board Member
 * Bob Linke, President & CEO
 * Dr. Yvonne Linney, Principal, Linney Bioconsulting
 * Ted W. Love, MD, Former CEO, Global Blood Therapeutics
 * Rick Lundberg, President and CEO, Eikonizo Therapeutics, Inc.
 * Nancy Lurker, CEO, CEO, EyePoint Pharmaceuticals, Inc.
 * Nagesh K. Mahanthappa, PhD, MBA, Executive Chair, Exo Therapeutics
 * Jon Martin
 * Sylvia McBrinn, Angel Investor, Former CEO, Axerion Therapeutics
 * Reenie McCarthy, Chief Executive Officer, Stealth BioTherapeutics
 * Sean McClain, Founder and CEO, Absci
 * Eileen McCullough, Serial Biotech Entrepreneur
 * Donnie McGrath, MD, MPH, Venture Partner, OrbiMed Advisors LLC
 * Medicines360
 * David Meeker MD, Chairman and CEO, Rhythm Pharmaceuticals
 * Darrin Miles, CEO & President, Nested Therapeutics
 * Jill C. Milne, PhD, CEO, Astria Therapeutics
 * Patrice M. Milos, PhD, Board Member, 54gene, SeqLL, Inc., ProThera Biologics and Vice President, Proof Diagnostics, Inc.
 * Emily Minkow, Biotech CEO
 * Jodie Morrison, Biotech CEO and Board Member
 * William J. Newell, CEO, Sutro Biopharma, Inc.
 * Nitrase Therapeutics, Inc.
 * Peter Noymer, PhD, Life Sciences CEO and Board Member
 * Julia Owens, CEO, Ananke Therapeutics
 * Raul Oliva, President, Sidekick Bio, Inc
 * Michael Quigley, PhD, President & CEO, Therini Bio
 * Rohan Palekar, CEO, 89bio Inc
 * Gisela A. Paulsen, MPharm, Former President & COO, Oncocyte Corporation, Entrepreneur-In-Residence, DigitalDX
 * Pfizer Inc.
 * RH Capital
 * Michael Raab, President and CEO, Ardelyx, Inc.
 * Debanjan Ray, CEO, Synthekine
 * Wendye Robbins, MD, Red Tower Partners Advisory
 * Holly Rockweiler, CEO, Madorra
 * René Russo, PharmD
 * George Scangos, PhD, CEO, Vir
 * Eef Schimmelpennink, President and CEO, Lenz Therapeutics
 * Second Genome, Inc.
 * Alicia Secor, President & CEO, Atalanta Therapeutics
 * Dr. Rona Z. Silkiss, Silkiss Eye Surgery
 * Nancy Simonian, CEO, Syros Pharmaceuticals
 * Jake Simson, Partner, RA Capital
 * Dr. Maria Soloveychik, PhD, CEO, SyntheX
 * Paula Soteropoulos, Biopharm Executive, Board Chairman, Venture Partner
 * Arthur Thomas Suckow, CEO, DTx Pharma
 * Shehnaaz Suliman, Biotech CEO
 * Synlogic Inc.
 * Laura Tadvalkar, Managing Director, RA Capital Management
 * James B. Trager, PhD, CSO, Nkarta Inc.
 * Alexis van Lingen, Head of Quality, Nkarta, Inc.
 * Ramani Varanasi, Biotech Executive
 * Chris Varma, PhD, Co-founder, Chairman, & CEO, Frontier Medicines Corporation
 * Katherine Vega Stultz, CEO & President, Ocelotbio
 * Dominique Verhelle, PhD, MBA, Biotech CEO
 * Sharon J. Vosmek, CEO & Managing Partner, Astia
 * Amanda Wagner, CEO
 * Hong I. Wan, President and CEO, Tallac Therapeutics
 * Wave Life Sciences
 * Yael Weiss, MD, PhD, Mahzi Therapeutics
 * Nancy Whiting, PharmD, CEO, Recludix Pharma
 * Fredrik Wiklund, Chief Executive Officer, Bright Peak Therapeutics
 * Leslie J. Williams, hC Bioscience, Inc., Co-Founder, President, and CEO
 * Katharine Yen, Biotech CEO
 * Angie You, CEO, Architect Therapeutics
 * Hanadie Yousef, PhD, Co-Founder and CEO, Juvena Therapeutics
 * Ashley Zehnder, CEO
 * Daphne Zohar, Founder & CEO, PureTech Health
 * Sandy Zweifach, Pelican Consulting Group, Inc.


 * City of New York, New York and NYC Health + Hospitals and County of Santa Clara, California in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 117, at 1 (5th Cir. Apr. 11, 2023).
 * City of New York and NYC Health + Hospitals, the County of Santa Clara, Los Angeles County, City and County of San Francisco, King County, and Cook County
 * Over 100 Reproductive Health, Rights, and Justice Organizations in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 123, at A-1–A-8 (5th Cir. Apr. 11, 2023).


 * A Woman's Choice of Charlotte, Greensboro, Raleigh, and Jacksonville
 * Abortion Access Front
 * Abortion Care Network
 * Access Reproductive Care (ARC)-Southeast
 * ACCESS Reproductive Justice
 * Advocates for Youth
 * All-Options
 * All* Above All Action Fund
 * American Civil Liberties Union
 * American Humanist Association
 * American Muslim Bar Association (AMBA)
 * American Society for Reproductive Medicine
 * Amnesty International USA
 * Avow
 * Black Women for Wellness
 * Black Women for Wellness Action Project
 * Catholics for Choice
 * Center for Reproductive Rights
 * Chicago Abortion Fund
 * Cobalt
 * Collective Power for Reproductive Justice
 * EMAA Project
 * Equality Labs
 * Feminist Majority Foundation
 * Feminist Women's Health Center
 * Florida Access Network
 * Fòs Feminista
 * Freedom From Religion Foundation
 * Frontera Fund
 * Fund Texas Choice
 * Gender Justice
 * Global Justice Center
 * Grandmothers for Reproductive Rights (GRR!)
 * Guttmacher Institute
 * HEART Women & Girls
 * Heartland Alliance International
 * Hope Clinic for Women
 * Human Impact Partners
 * Ibis Reproductive Health
 * If/When/How: Lawyering for Reproductive Justice
 * In Our Own Voice: National Black Women's Reproductive Justice Agenda
 * Ipas
 * Jane’s Due Process
 * Jewish Women International
 * Just The Pill/Abortion Delivered
 * Justice for Muslims Collective
 * Lilith Fund
 * Love Me Unlimited 4 Life
 * Mabel Wadsworth Center
 * Medical Students for Choice
 * Miscarriage + Abortion Hotline
 * Ms. Foundation for Women
 * NARAL Pro-Choice America
 * National Abortion Federation
 * National Advocates for Pregnant Women
 * National Asian Pacific American Women's Forum (NAPAWF)
 * National Birth Equity Collaborative
 * National Center for Lesbian Rights
 * National Council of Jewish Women
 * National Council of Jewish Women Greater Dallas
 * National Family Planning & Reproductive Health Association
 * National Health Law Program
 * National Institute for Reproductive Health
 * National Latina Institute for Reproductive Justice
 * National Network of Abortion Funds
 * National Organization for Women
 * National Partnership for Women & Families
 * National Women’s Health Network
 * National Women’s Law Center
 * National Women's Political Caucus
 * Nebraska Abortion Resources (NEAR)
 * New Mexico Religious Coalition for Reproductive Choice
 * New Orleans Abortion Fund
 * New River Abortion Access Fund
 * Northland Family Planning Centers
 * NWAAF
 * PAI
 * Pathfinder International
 * People For the American Way
 * Physicians for Reproductive Health
 * Planned Parenthood Federation of America
 * Population Institute
 * Power to Decide
 * Pregnancy Options WI: Education,
 * Resources & Support, Inc.
 * Pro-Choice Connecticut
 * Pro-Choice Maryland
 * Pro-Choice Missouri
 * Pro-Choice North Carolina
 * Pro-Choice Ohio
 * Pro-Choice Oregon
 * Pro-Choice Virginia
 * Pro-Choice Washington
 * Queer Crescent
 * Reclaim/ MI WIN Abortion Fund
 * Reproaction
 * Reproductive Equity Now
 * Reproductive Health Access Project
 * Rhia Ventures
 * Right By You
 * SHERo Mississippi
 * SIECUS: Sex Ed for Social Change
 * SisterLove Inc.
 * SisterSong: Women of Color Reproductive Justice Collective
 * Society for Maternal-Fetal Medicine
 * State Innovation Exchange (SiX)
 * Supermajority
 * Tampa Bay Access Force, Inc.
 * Texas Equal Access Fund
 * The Afiya Center
 * The Womxn Project
 * UltraViolet
 * Union for Reform Judaism
 * URGE: Unite for Reproductive & Gender Equity
 * We Testify
 * White Ribbon Alliance
 * Whole Woman's Health Alliance
 * Women of Reform Judaism
 * Women with a Vision
 * Women's Medical Fund, Inc.
 * Women's March
 * Yellowhammer Fund
 * YWCA Kalamazoo
 * &#8203;#VOTEPROCHOICE
 * 2+ Abortions Worldwide


 * American Center for Law and Justice in opposition to motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 122, at 1 (5th Cir. Apr. 11, 2023).
 * Former U.S. Department of Justice Officials in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 116, at i–iv (5th Cir. Apr. 11, 2023).


 * Kent B. Alexander, U.S. Attorney, Northern District of Georgia (1994-1997)
 * Donna A. Bucella, U.S. Attorney, Middle District of Florida (1999-2001)
 * Leslie R. Caldwell, Assistant Attorney General for the Criminal Division, U.S. Department of Justice (2014-2017)
 * Robert L. Capers, U.S. Attorney General, Eastern District of New York (2015-2017)
 * Zachary W. Carter, U.S. Attorney, Eastern District of New York (1993-1999)
 * Tristram Coffin, U.S. Attorney, District of Vermont (2009-2015)
 * James M. Cole, Deputy Attorney General, U.S. Department of Justice (2011-2015)
 * Michael W. Cotter, U.S. Attorney, District of Montana (2009-2017)
 * Deirdre M. Daly, U.S. Attorney, District of Connecticut (2013-2017)
 * Edward L. Dowd Jr., U.S. Attorney, Eastern District of Missouri (1993-1999)
 * Paul J. Fishman, U.S. Attorney, District of New Jersey (2009-2017)
 * Benjamin C. Glassman, U.S. Attorney, Southern District of Ohio (2016-2019)
 * Booth Goodwin, U.S. Attorney, Southern District of West Virginia (2010-2015)
 * Jamie S. Gorelick, Deputy Attorney General, U.S. Department of Justice (1994-1997)
 * Melinda Haag, U.S. Attorney, Northern District of California (2010-2015)
 * David Hickton, U.S. Attorney, Western District of Pennsylvania (2010-2016)
 * Stephen L. Hill, Jr., U.S. Attorney, Western District of Missouri (1993-2001)
 * Eric H. Holder, U.S. Attorney General, U.S. Department of Justice (2009-2015); Deputy Attorney General, U.S. Department of Justice (1997-2001); U.S. Attorney, District of Columbia (1993-1997)
 * Dwight C. Holton, U.S. Attorney, District of Oregon (2010-2011)
 * John Horn, U.S. Attorney, Northern District of Georgia (2015-2017)
 * Jose de Jesus Rivera, U.S. Attorney, District of Arizona (1998-2000)
 * Brendan V. Johnson, U.S. Attorney, District of South Dakota (2009-2015)
 * Doug Jones, U.S. Attorney, Northern District of Alabama (1997-2001)
 * Bill Killian, U.S. Attorney, Eastern District of Tennessee (2010-2015)
 * Jim Lewis, U.S. Attorney, Central District of Illinois (2010-2016)
 * Loretta E. Lynch, Attorney General of the United States, U.S. Department of Justice (2015-2017); U.S. Attorney, Eastern District of New York (1999-2002, 2010-2015)
 * Kenneth Magidson, U.S. Attorney, Southern District of Texas (2011-2017)
 * Jerry E. Martin, U.S. Attorney, Middle District of Tennessee (2010-2013)
 * Mary B. McCord, Acting Assistant Attorney General for National Security, U.S. Department of Justice (2014-2017)
 * Zane David Memeger, U.S. Attorney, Eastern District of Pennsylvania (2010-2016)
 * Eric Miller, U.S. Attorney, District of Vermont (2015-2017)
 * Thomas Monaghan, U.S. Attorney, District of Nebraska (1993-2001)
 * Florence T. Nakakuni, U.S. Attorney, District of Hawaii (2009-2017)
 * Bill Nettles, U.S. Attorney, District of South Carolina (2010-2016)
 * Denise E. O’Donnell, U.S. Attorney, Western District of New York (1997-2001)
 * David W. Ogden, Deputy Attorney General of the U.S., U.S. Department of Justice (2009-2010); Assistant Attorney General for Civil Division, U.S. Department of Justice (1999-2001)
 * Wendy J. Olson, U.S. Attorney, District of Idaho (2010-2017)
 * Carmen M. Ortiz, U.S. Attorney, District of Massachusetts (2009-2017)
 * Timothy Q. Purdon, U.S. Attorney, District of North Dakota (2010-2015)
 * Ripley Rand, U.S. Attorney, Middle District of North Carolina (2011-2017)
 * Sarah R. Saldaña, U.S. Attorney, Northern District of Texas (2011-2014)
 * Randy Seiler, U.S. Attorney, District of South Dakota (2015-2017)
 * Donald K. Stern, U.S. Attorney, District of Massachusetts (1993-2001)
 * Charles J. Stevens, U.S. Attorney, Eastern District of California (1994-1997)
 * Carter Stewart, U.S. Attorney, Southern District of Ohio (2009-2016)
 * Thomas Strickland, U.S. Attorney, District of Colorado (1999-2001)
 * Edward J. Tarver, U.S. Attorney, Southern District of Georgia (2009-2017)
 * Lee Thompson, U.S. Attorney, District of Kansas (1990-1993)
 * Anne Tompkins, U.S. Attorney, Western District of North Carolina (2010-2015)
 * Stanley A. Twardy, Jr., U.S. Attorney, District of Connecticut (1985-1991)
 * John W. Vaudreuil, U.S. Attorney, Western District of Wisconsin (2010-2017)
 * Benjamin B. Wagner, U.S. Attorney, Eastern District of California (2009-2016)
 * Seth P. Waxman, Solicitor General of the United States, U.S. Department of Justice (1997-2001)
 * Billy J. Williams, U.S. Attorney, District of Oregon (2015-2021)
 * Sally Yates, Acting Attorney General (2017); Deputy Attorney General (2015-2017); U.S. Attorney for the Northern District of Georgia (2010-2015)


 * NAACP Legal Defense and Educational Fund, Incorporated in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 115, at 1 (5th Cir. Apr. 11, 2023).
 * Charlotte Lozier Institute in opposition to motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 113, at 1 (5th Cir. Apr. 11, 2023).
 * Former FDA Officials in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 112, at 2 (5th Cir. Apr. 11, 2023).
 * Stephen Ostroff, M.D., who served in various positions at FDA from 2013 to 2019, including Acting Commissioner of Food and Drugs (2015-16 and 2017) and FDA Chief Scientist (2014-15).
 * Suzanne Junod, Ph.D., who served as a historian at FDA from 1984 to 2018.
 * Christ Medicus Foundation, Catholic Benefits Association, Catholic Bar Association, National Catholic Bioethics Center, Catholic Health Care Leadership Alliance and Susan B. Anthony Pro-Life America in opposition to motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 100, at 1–2 (5th Cir. Apr. 11, 2023).
 * Medical and Public Health Societies in support of motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 111, at iii (5th Cir. Apr. 12, 2023).


 * American College of Obstetricians and Gynecologists
 * American Medical Association
 * Society for Maternal-Fetal Medicine
 * American Academy of Nursing
 * American Academy of Pediatrics
 * American College of Nurse-Midwives
 * American Society for Reproductive Medicine
 * Council of University Chairs of Obstetrics and Gynecology
 * North American Society for Pediatric and Adolescent Gynecology
 * Society of Family Planning
 * Society of Gynecologic Oncology
 * Society of OB/GYN Hospitalists


 * State of Missouri in opposition to motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 168, at 1 (5th Cir. Apr. 12, 2023).
 * State of West Virginia in opposition to motion for stay
 * Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, No. 23-10362, ECF No. 132, at 1 (5th Cir. Apr. 12, 2023).
 * Pending Motions
 * ECF No. 130 (Apr. 12, 2023), States of Mississippi, Alabama, Arkansas, Florida, Georgia, Indiana, Iowa, Kansas, Kentucky, Louisiana, Montana, Nebraska, Ohio, South Carolina, South Dakota, Tennessee, Texas, Utah, and Wyoming.
 * — Preceding unsigned comment added by TE(æ)A,ea. (talk • contribs)


 * Please note that we do NOT include amicus brief details in these types of cases unless the amicus briefs are described by third parties. The briefs themselves are primary sources and may be self-serving, but through the eye of a reliable third party we get the relative importance of these. Also, calling out which lawmakers are for or against a case, without third-parties making that claim, is a non-neutral presentation of the information. --M asem (t) 02:14, 13 April 2023 (UTC)
 * I referenced Texas v. Pennsylvania in the edit summary, where they did just that. TE(æ)A,ea. (talk) 15:57, 13 April 2023 (UTC)
 * Where rhe names were reported in third party sources. You are still relying on primary court documents here. M asem (t) 15:08, 20 April 2023 (UTC)

Article name
Should the name of this article be changed to Alliance for Hippocratic Medicine v. FDA per Bluebook? Brad (talk) 05:33, 19 April 2023 (UTC)


 * Yes, I've gone ahead and moved it. The lead still has the full name. M asem (t) 15:19, 20 April 2023 (UTC)